The E3 protein ubiquitin ligase Itch is a potential target in myeloid malignancies with marrow fibrosis

Shuang Han1, Yao Zhang1, Cha Guo1

  • 1Department of Hematology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.

Abstract

Insights

The E3 ubiquitin ligase Itch may contribute to myeloid malignancies like myelodysplastic syndrome and acute myeloid leukemia by influencing proliferation and fibrosis. Its expression increases with higher white blood cell counts in these diseases.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • The mechanisms driving myeloid malignancies, including myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) with bone marrow fibrosis, remain unclear.
  • This study investigates the preliminary role of the E3 protein ubiquitin ligase Itch in the pathogenesis of these conditions.

Purpose of the Study:

  • To explore the potential involvement of the E3 ubiquitin ligase Itch in myeloid malignancies.
  • To investigate the relationship between the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and Itch expression in myeloid neoplasms.

Main Methods:

  • Bioinformatic analysis to identify potential roles of Itch and the PI3K/Akt pathway.
  • In vitro experiments using the K562 myeloid neoplasm cell line to assess PI3K/Akt regulation of Itch and p73.
  • Quantitative analysis of Itch mRNA levels in clinical samples from various myeloid disease subgroups.

Main Results:

  • The PI3K/Akt pathway did not appear to regulate Itch or its substrate p73 in the K562 cell line.
  • Itch mRNA levels were significantly elevated in patients with high-risk MDS, AML, fibrosis, and higher white blood cell (WBC) counts compared to controls.
  • Itch mRNA levels showed a positive correlation with WBC count but no significant difference based on karyotype.

Conclusions:

  • The PI3K/Akt pathway is unlikely involved in regulating Itch expression in myeloid tumors.
  • Itch may play a significant role in both the proliferation and fibrosis development characteristic of myeloid malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K